194 related articles for article (PubMed ID: 11465962)
1. The HOPE study: comparison with other trials of secondary prevention.
Otterstad JE; Sleight P
Eur Heart J; 2001 Aug; 22(15):1307-10. PubMed ID: 11465962
[No Abstract] [Full Text] [Related]
2. Effect of ramipril on cardiovascular events in high-risk patients.
Weinsaft JW
N Engl J Med; 2000 Jul; 343(1):64; author reply 66. PubMed ID: 10896543
[No Abstract] [Full Text] [Related]
3. What is the relevance of the HOPE study in general practice?
Kennedy J; Mogensen CE; Ball SG; Castaigne AD; Commerford PJ; Distiller L; Fisher BM; Gonzalez-Jaunatey J; Nosadini R; Novials A; Ostergren J; Palma-Gámiz J; Perrone-Filardi P; Schipperheijn JJ; Senges J; Trevisan R
Int J Clin Pract; 2001 Sep; 55(7):449-57. PubMed ID: 11594254
[TBL] [Abstract][Full Text] [Related]
4. Ramipril.
Smith WH; Ball SG
Int J Clin Pract; 2000 May; 54(4):255-60. PubMed ID: 10912316
[TBL] [Abstract][Full Text] [Related]
5. The HOPE Study (Heart Outcomes Prevention Evaluation).
Sleight P
J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
[TBL] [Abstract][Full Text] [Related]
6. [The reduction of cardiovascular risk with ramipril].
Vanuzzo D
Ital Heart J Suppl; 2000 May; 1(5):713-4. PubMed ID: 10834142
[No Abstract] [Full Text] [Related]
7. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Rapezzi C; Ciliberti P; Graziosi M; Riva L
Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke.
Fletcher GF; Bufalino V; Costa F; Goldstein LB; Jones D; Smaha L; Smith SC; Stone N
Am J Cardiol; 2007 Mar; 99(6C):1E-35E. PubMed ID: 17378996
[No Abstract] [Full Text] [Related]
9. [Further options with ramipril. Besides cardio- and nephro-protection diabetes prevention, too?].
MMW Fortschr Med; 2003 Sep; 145(39):47. PubMed ID: 14649075
[No Abstract] [Full Text] [Related]
10. ACE inhibitors to prevent cardiovascular events in high-risk patients.
VandeKieft GK
J Fam Pract; 2000 Apr; 49(4):373-4. PubMed ID: 10778846
[No Abstract] [Full Text] [Related]
11. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].
Ceconi C; Mastrorilli F; Squasi PA; Gaitani S; Guardigli G; Ferrari R
Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512
[TBL] [Abstract][Full Text] [Related]
13. Current indications for ACE inhibitors and HOPE for the future.
Burch S; Ou N
Am J Manag Care; 2002 May; 8(5):478-90; quiz 491-3. PubMed ID: 12019599
[TBL] [Abstract][Full Text] [Related]
14. Prevention of cardiovascular ischemic events: high-risk and secondary prevention.
Genest J; Pedersen TR
Circulation; 2003 Apr; 107(15):2059-65. PubMed ID: 12707251
[No Abstract] [Full Text] [Related]
15. [HOPE study].
Katayama S
Nihon Rinsho; 2006 Aug; 64 Suppl 6():475-9. PubMed ID: 16983779
[No Abstract] [Full Text] [Related]
16. [Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials].
Lièvre M
Rev Prat; 2001 Oct; 51(16):1793-9. PubMed ID: 11795124
[TBL] [Abstract][Full Text] [Related]
17. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.
Gerstein HC
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S82-5. PubMed ID: 12324991
[TBL] [Abstract][Full Text] [Related]
18. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
Ferrari R; Ambrosio G; Chiariello M
Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511
[No Abstract] [Full Text] [Related]
19. Don't keep that ACE (inhibitor) up your sleeve! Is ramipril effective for secondary prevention of cardiovascular disease and stroke?
Hammett DC; MacFadyen JC
Can Fam Physician; 2000 Apr; 46():821-3. PubMed ID: 10790814
[No Abstract] [Full Text] [Related]
20. More than just hype.
Fitchett D
CMAJ; 2003 Jun; 168(13):1646-7; author reply 1647-8. PubMed ID: 12821613
[No Abstract] [Full Text] [Related]
[Next] [New Search]
